Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCLC Stage A Hepatocellular Carcinoma”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Testing effectiveness (Phase 2)Study completedNCT01900002
What this trial is testing

Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaRecurrent Adult Hepatocellular Carcinoma+8 more
M.D. Anderson Cancer Center 40
Not applicableNot Yet RecruitingNCT06971237
What this trial is testing

SIRT and Peri-immunotherapy : a New Concept

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC), Classified as BCLC Stage B or C, Treated With a Combination of Selective Internal Radiation Therapy
Assistance Publique - Hôpitaux de Paris 60
Not applicableUnknownNCT01470495
What this trial is testing

Combined Treatment of RFA and Sorafenib on Recurrent HCC

Who this might be right for
HCCRadiofrequency AblationSorafenib
Southwest Hospital, China 430
Testing effectiveness (Phase 2)UnknownNCT03520257
What this trial is testing

The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 50
Testing effectiveness (Phase 2)UnknownNCT05883176
What this trial is testing

TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria

Who this might be right for
Hepatocellular Carcinoma by BCLC Stage
Sun Yat-sen University 35
Not applicableStudy completedNCT05117047
What this trial is testing

A Long-term Survival Analysis of Different Surgical Method in Early Hepatocellular Carcinoma

Who this might be right for
Long-term Effects of Cancer Treatment
Chen Xiaoping 369
Not applicableLooking for participantsNCT07436845
What this trial is testing

Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy

Who this might be right for
Hepatocellular Carcinoma (HCC)Emotional DistressHAIC(Hepatic Artery Infusion Chemotherapy)+2 more
Nanfang Hospital, Southern Medical University 90
Testing effectiveness (Phase 2)Study completedNCT02940496
What this trial is testing

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatitis C Infection+8 more
M.D. Anderson Cancer Center 15
Not applicableUnknownNCT01764438
What this trial is testing

Utility Study of Primovist-MRI on HCC Staging

Who this might be right for
Hepatocellular Carcinoma
Inha University Hospital 174
Early research (Phase 1)Study completedNCT01666756
What this trial is testing

Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerAdvanced Adult Hepatocellular Carcinoma+2 more
City of Hope Medical Center 18
Testing effectiveness (Phase 2)UnknownNCT04796025
What this trial is testing

TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 34
Early research (Phase 1)Not Yet RecruitingNCT06994572
What this trial is testing

Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Captor Therapeutics S.A. 141
Testing effectiveness (Phase 2)WithdrawnNCT05327738
What this trial is testing

Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+2 more
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT04828486
What this trial is testing

Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage A Hepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma+2 more
Mayo Clinic 14
Testing effectiveness (Phase 2)Looking for participantsNCT06607107
What this trial is testing

MFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 29
Testing effectiveness (Phase 2)UnknownNCT04597970
What this trial is testing

TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC

Who this might be right for
Transarterial ChemoembolizationHepatocellular Carcinoma
Peking University Cancer Hospital & Institute 66
Testing effectiveness (Phase 2)Study completedNCT05622071
What this trial is testing

Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions

Who this might be right for
Hepatocellular Carcinoma by BCLC Stage
UNICANCER 50
Early research (Phase 1)Study completedNCT03515252
What this trial is testing

Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IVHepatocellular Carcinoma by BCLC Stage+2 more
Ivy Life Sciences, Co., Ltd 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05507632
What this trial is testing

Donafenib Plus Sintilimab in Combination With TACE in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 48
Not applicableStudy completedNCT06261138
What this trial is testing

Survival Analysis: TACE vs. Combination Therapy in HCC

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 279
Load More Results